Locations:

Tag: multiple sclerosis (MS)

July 31, 2019/Neurosciences/Research

Piloting a Powered Exoskeleton for Gait Training in Multiple Sclerosis

New study aims to assess a potential new indication for the technology

June 4, 2019/Neurosciences/Research

Virtual Reality Platform’s Dynamic Approach to Physical Therapy Yields Benefits in MS

Preliminary study finds improved gait and balance vs. traditional PT

May 7, 2019/Neurosciences/Research

Assessing Deep Gray Matter Atrophy as a Predictor of Clinical Disability in MS

Study finds strong association between brain/thalamic volume and T2 lesion volume

May 7, 2019/Neurosciences/Research

Highly Effective Therapies Used in Only a Minority of Relapsing MS Cases, Study Finds

Prescribing practices analyzed over 12+ years across 10 sites

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

May 6, 2019/Neurosciences/Research

SPRINT-MS Subanalysis Shows Greater Effect for Ibudilast in Primary Vs. Secondary Progressive MS

Findings may be due to faster atrophy progression in primary progressive MS

19-NEU-258-Woman-MS-Wheelchair-640241694

March 27, 2019/Neurosciences/Research

A Window into Patients’ Perceptions of the Risks of Multiple Sclerosis Therapies

Large survey shows wide variability in risk tolerance, high levels of risk aversion

March 7, 2019/Neurosciences/Technology & Innovation

Dr. Robert Fox Receives Innovation Award for Advances in Progressive Multiple Sclerosis (Video)

Honor recognizes imaging and therapeutic insights behind slowing of brain atrophy

March 1, 2019/Neurosciences/Advancing Patient Care

Tech-Enabled Data Capture Promises New Level of Comprehensiveness in Routine Multiple Sclerosis Care

Study signals potential for enhanced patient monitoring

18-NEU-5687-myelocortical-multiple-sclerosis-650×450

November 26, 2018/Basic & Translational Science

Myelocortical Multiple Sclerosis: Neurodegeneration Without White Matter Demyelination

Discovery of new MS subtype suggests that the axon itself may be primary site of injury

November 12, 2018/Neurosciences/Research

Disease-Modifying Therapy for MS: Discontinuing After Age 60 Appears Safe

Observational study suggests age may be a better guide than disease stability

BackPage 7 of 9Next